Placeholder

$5,375.00$8,175.00

Clear
SKU: N/A Category:

Diabetes Care Devices & Drugs Market- Global Opportunity Analysis and Industry Forecast (2017-2022)

  • Oct, 2017
  • pages: 217
  • formats:* PDF
  • Report ID: MRPH-10407

Product Description

Global Diabetes Care Devices & Drugs Market by Type of Devices (Continuous Blood Glucose Monitoring Devices, Test Strips, Lancets, Self-monitoring Devices, Haemoglobin A1c Testing Kits, Insulin Syringes, Insulin Pens, Insulin Pumps, Insulin Jet Injectors), and Drugs (Insulin, Oral Hypoglycaemic Agents, and Non-Insulin Injectable) – Global Opportunity Analysis and Industry Forecast To 2022 

Diabetes is one of the largest global health emergencies of the 21st century. Each year more and more people live with this condition, which can result in life-changing complications. In addition to the 415 million adults who are estimated to have diabetes globally in 2015, there are 318 million adults with impaired glucose tolerance, which puts them at high risk of developing the chronic disease in the future. The incidence & prevalence of diabetes is growing with rising obesity rates, changing lifestyle and dietary habits, and growing ageing population. Therefore, given the huge numbers of diabetics worldwide and the huge financial implications associated with diabetes and related further health complications, there is a substantial market potential in the global diabetes care devices & drugs market in the next 5-10 years. The global diabetes care devices & drugs market are expected to grow at a CAGR of 5.2% from 2017 to 2022 to reach $85,591.2 million by 2022.

Following a comprehensive research on the global diabetes care devices & drugs market and an in-depth analysis of the market scenario, the report carries out an impact analysis of the key industry drivers, restraints, and opportunities, listed in the market insights segment. Increasing incidence & prevalence of diabetes, technological advancements, rise in obesity, and increasing sedentary lifestyle and improper diet are the key market drivers covered in the report which will support the industry growth in the forecast period. However, high cost associated with diagnosis and treatment, reimbursement issues, and lack of awareness are the major pain points, restraining the adoption of the diabetes care devices & drugs market in various countries across the globe.

The report further gives an extensive outlook on the multifarious segments and sub-segments in both diabetes care devices and drugs market. The diabetes care devices market further talks about the trends impacting the growth of diabetes monitoring devices and insulin delivery devices including their sub-segments. The diabetes care drugs market in detail speaks about insulin, oral-hypoglycemic drugs, and non-insulin injectable drugs.

An exhaustive analysis of the geographical scenario of the industry for the five major geographies: North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa is included in the geographical analysis section. These regions are further analyzed at a country level with the detailed qualitative and quantitative analysis. The geographical analysis provides detailed insights on the key trends of the industry in the listed regions & countries, identifying the disease incidence & prevalence, demographic & economic impact, government & private investments, and regulatory scenario. The report identifies North America to be the largest market, followed by Europe, Asia-Pacific, Latin America and Middle East & Africa. The geographical analysis section also comments on the key market players shaping the growth of the industry in the respective countries.

Global Diabetes Care Devices & Drugs Market, by Geography, 2017-2022

Diabetes care devices & drugs market

The report also includes the competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 3 years (2015-2017). The study has also incorporated the market share analysis of leading players in each of the diabetes care devices and drugs market, and detailed profiles of 15 top market players across the value chain of the industry, including detailed financial performance, product offerings, and strategic growth initiatives of each player.

The key players operating in the global diabetes care devices & drugs market are Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), Abbott Laboratories (U.S.), Ascensia Diabetes Care Holdings AG (Switzerland), Eli Lilly and Company (U.S.), Hoffmann-La Roche Ltd.(Switzerland), Johnson & Johnson (U.S.), Medtronic PLC (Ireland), Becton, Dickinson and Company (U.S.), Terumo Corporation (Japan), Sanofi S.A. (France), Merck & Co., Inc.(U.S.), Novartis AG (Switzerland), AstraZeneca PLC (U.K.), and Boehringer Ingelheim GmbH (Germany).

Key questions answered in the report: 

Increasing incidence & prevalence of diabetes to drive the adoption of diabetes care devices & drugs market

  • How does the penetration of diabetes care devices differ from the penetration of diabetes care drugs?
  • Which are the high growth market segments in terms of product type, and regions/countries?

The North American diabetes care devices & drugs market favors both larger and local manufacturers that compete in multiple segments

  • Who are the top competitors in this market and what strategies do they employ to gain shares?
  • What is driving the growth and which market segments have the most potential for revenue expansion over the forecast period?
  • What strategies should new companies looking to enter this market use to compete effectively?
  • What are the major drivers, restrains, and opportunities in the global diabetes care devices & drugs market?
  • Who are the major players in various countries and what share of the market do they hold?
  • What are the geographical trends and high growth regions/ countries?

Recent collaborations, partnerships, expansions, and agreements taken place in the diabetes care devices & drugs space.

  • What companies have recently formed partnerships/collaborations/agreements and how will these unions affect the competitive landscape of the diabetes care devices & drugs space?
  • Which companies have recently received approvals for innovative devices/drugs and how will these approvals promote a competitive advantage?
  • Who are the major players in the global diabetes care devices & drugs market and what share of the market do they hold?
  • Who are the local emerging players in the global diabetes care devices & drugs market and how do they compete with the global players?

Scope of the Report

Market by Product

Diabetes care devices

  • Diabetes monitoring devices
    • Test strips
    • Self-monitoring devices
    • Continuous blood glucose monitoring devices
    • Lancets
    • Hemoglobin A1c testing kits
  • Insulin delivery devices
    • Insulin Pens
    • Insulin Syringes
    • Insulin Pumps
    • Insulin Jet Injectors

Diabetes care drugs

  • Insulin
    • Rapid-acting insulin drugs
    • Short-acting insulin drugs
    • Intermediate-acting insulin drugs
    • Long-acting insulin drugs
  • Oral-hypoglycaemic drugs
    • Biguanides (Metformin)
    • Sulfonylureas
    • Meglitinides/ Phenylalanine analogues
    • Thiazolidinedione analogues
    • α-glucosidase inhibitors
    • DPP-IV Inhibitors
  • Non-insulin injectable drugs

Market by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • Rest of World
    • Latin America
    • The Middle East and Africa

 

 

 

TABLE OF CONTENT

1. Introduction

1.1. Market Ecosystem
1.2. Currency and Limitations

1.2.1. Currency
1.2.2. Limitations

1.3. Key Stakeholders

2. Research Methodology

2.1. Research Process

2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation

3. Executive Summary
4. Market Insights

4.1. Introduction
4.2. Drivers

4.2.1. Increasing Incidence & Prevalence of Diabetes
4.2.2. Technological Advancements
4.2.3. Rise in Obesity
4.2.4. Increasing Sedentary Lifestyle and Improper Diet
4.2.5. Other Drivers

4.3. Restraints

4.3.1. High Cost Associated with Diagnosis and Treatment
4.3.2. Reimbursement Issues
4.3.3. Lack of Awareness
4.3.4. Other Restraints

4.4. Opportunities

4.4.1. Development of New Formulations and Insulin Delivery Technologies
4.4.2. Other Opportunities

4.5. Challenges

4.5.1. Stringent Regulations and Registration Process
4.5.2. Other Challenges

4.6. Regulatory Analysis

4.6.1. North America
4.6.2. Europe
4.6.3. Asia-Pacific

4.7. Market Share Analysis

4.7.1. Diabetes Care Devices
4.7.2. Diabetes Care Drugs

5. Diabetes Care Devices Market, By Type

5.1. Introduction
5.2. Diabetes Monitoring Devices

5.2.1. Continuous Blood Glucose Monitoring Devices
5.2.2. Test Strips
5.2.3. Lancets
5.2.4. Self-Monitoring Blood Glucose Devices
5.2.5. Haemoglobin A1c Testing Kits

5.3. Insulin Delivery Devices

5.3.1. Insulin Syringes
5.3.2. Insulin Pens
5.3.3. Insulin Pumps
5.3.4. Insulin Jet Injectors

6. Diabetes Care Drugs Market, By Type

6.1. Introduction
6.2. Insulin

6.2.1. Rapid Acting Insulin
6.2.2. Short Acting Insulin
6.2.3. Intermediate Acting Insulin
6.2.4. Long Acting Insulin

6.3. Oral Hypoglycaemic Drugs

6.3.1. Sulfonylureas
6.3.2. Biguanides
6.3.3. Meglitinides / Phenylalanines Analogues
6.3.4. Thiazolidinediones
6.3.5. Alpha-Glucosidase Inhibitors
6.3.6. Di-Peptidyl Peptidase -4 (DPP-4) Inhibitor

6.4. Non-Insulin Injectable Drugs

7. Diabetes Care Devices & Drugs Market, By Geography

7.1. Introduction
7.2. North America

7.2.1. U.S.
7.2.2. Canada

7.3. Europe

7.3.1. Germany
7.3.2. France
7.3.3. Italy
7.3.4. Spain
7.3.5. U.K.
7.3.6. RoE

7.4. Asia-Pacific

7.4.1. Japan
7.4.2. China
7.4.3. India
7.4.4. RoAPAC

7.5. RoW

7.5.1. Latin America
7.5.2. Middle East & Africa

8. Competitive Landscape

8.1. Collaborations, Partnerships & Agreements
8.2. Approvals
8.3. New Product Launches
8.4. Expansions
8.5. Acquisitions
8.6. Others

9. Company Profiles
(Business overview, ,Financials, Product portfolio, and Recent developments)

9.1. Novo Nordisk A/S
9.2. Ypsomed AG
9.3. Abbott Laboratories
9.4. Ascensia Diabetes Care Holdings AG
9.5. Eli Lilly And Company
9.6. Hoffmann-La Roche Ltd.
9.7. Johnson & Johnson
9.8. Medtronic Plc
9.9. Becton, Dickinson And Company
9.10. Terumo Corporation
9.11. Sanofi S.A.
9.12. Merck & Co., Inc.
9.13. Novartis Ag
9.14. Astrazeneca
9.15. Boehringer Ingelheim GmbH

10. Appendix

10.1. Questionnaire
10.2. Available Customization

LIST OF TABLES & FIGURES

List of Tables

Table 1 Diabetes Care Devices & Drugs Market Drivers: Impact Analysis (2017–2022)
Table 2 Technological Advancements, By Company
Table 3 Diabetes Care Devices & Drugs Market Restraints: Impact Analysis (2017–2022)
Table 4 Proportion And Number of People (20-79 Years) Living With Diabetes Who Are Undiagnosed, 2015
Table 5 Global Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
Table 6 Global Diabetes Care Devices Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 7 Global Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
Table 8 Global Diabetes Monitoring Devices Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 9 Global Continuous Glucose Monitoring Devices Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 10 Global Test Strips Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 11 Global Lancets Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 12 Global Self-Monitoring Bloob Glucose Devices Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 13 Global Hemoglobin A1c Testing Kits Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 14 Global Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
Table 15 Global Insulin Delivery Devices Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 16 Global Insulin Syringes Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 17 Global Insulin Pens Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 18 Global Insulin Pumps Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 19 Global Insulin Jet Injectors Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 20 Global Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 21 Global Diabetes Care Drugs Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 22 Global Insulin Market Size, by Type, 2015-2022 (USD Million)
Table 23 Global Insulin Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 24 Global Rapid-Acting Insulin Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 25 Global Short-Acting Insulin Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 26 Global Intermediate-Acting Insulin Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 27 Global Long-Acting Insulin Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 28 Global Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 29 Global Oral-Hypoglycaemic Drugs Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 30 Global Sulfonylureas Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 31 Global Biguanides Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 32 Global Meglitinides/ Phenylalanine Analogues Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 33 Global Thiazolidinedione Analogues Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 34 Global Alpha-Glucosidase Inhibitors Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 35 Global DPP-4 Inhibitors Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 36 Global Non-Insulin Injectable Drugs Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 37 Global Diabetes Care Devices & Drugs Market Size, by Country/ Region, 2015-2022 (USD Million)
Table 38 North America: Diabetes Care Devices & Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 39 North America: Diabetes Care Devices & Drugs Market Size, by Country, 2015-2022 (USD Million)
Table 40 North America: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
Table 41 North America: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
Table 42 North America: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
Table 43 North America: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 44 North America: Insulin Market Size, by Type, 2015-2022 (USD Million)
Table 45 North America: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 46 U.S.: Diabetes Indicators, 2016
Table 47 Estimated Number and Percentage of Diagnosed And Undiagnosed Diabetes Among Adults Aged =18 Years, U.S., 2015
Table 48 Drugs Approved by FDA From 2012-2017 for Treatment of Diabetes
Table 49 U.S.: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
Table 50 U.S.: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
Table 51 U.S.: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
Table 52 U.S.: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
Table 53 U.S.: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 54 U.S.: Insulin Market Size, by Type, 2015-2022 (USD Million)
Table 55 U.S.: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 56 Diabetes Statistics in Canada, 2016-2026
Table 57 Canada: Diabetes Indicators, 2016
Table 58 Canada: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
Table 59 Canada: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
Table 60 Canada: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
Table 61 Canada: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
Table 62 Canada: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 63 Canada: Insulin Market Size, by Type, 2015-2022 (USD Million)
Table 64 Canada: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 65 Europe: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
Table 66 Europe: Diabetes Care Devices & Drugs Market Size, by Country, 2015-2022 (USD Million)
Table 67 Europe: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
Table 68 Europe: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
Table 69 Europe: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
Table 70 Europe: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 71 Europe: Insulin Market Size, by Type, 2015-2022 (USD Million)
Table 72 Europe: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 73 Germany: Diabetes Indiactors, 2016
Table 74 Germany: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
Table 75 Germany: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
Table 76 Germany: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
Table 77 Germany: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
Table 78 Germany: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 79 Germany: Insulin Market Size, by Type, 2015-2022 (USD Million)
Table 80 Germany: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 81 France: Diabetes Indicators, 2016
Table 82 France: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
Table 83 France: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
Table 84 France: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
Table 85 France: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
Table 86 France: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 87 France: Insulin Market Size, by Type, 2015-2022 (USD Million)
Table 88 France: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 89 Italy: Diabetes Indicators, 2016
Table 90 Italy: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
Table 91 Italy: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
Table 92 Italy: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
Table 93 Italy: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
Table 94 Italy: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 95 Italy: Insulin Market Size, by Type, 2015-2022 (USD Million)
Table 96 Italy: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 97 Spain: Diabetes Indicators, 2016
Table 98 Spain: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
Table 99 Spain: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
Table 100 Spain: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
Table 101 Spain: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
Table 102 Spain: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 103 Spain: Insulin Market Size, by Type, 2015-2022 (USD Million)
Table 104 Spain: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 105 U.K.: Diabetes Indicators, 2016
Table 106 U.K.: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
Table 107 U.K: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
Table 108 U.K: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
Table 109 U.K.: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
Table 110 U.K.: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 111 U.K.: Insulin Market Size, by Type, 2015-2022 (USD Million)
Table 112 U.K.: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 113 RoE: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
Table 114 RoE: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
Table 115 RoE: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
Table 116 RoE: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
Table 117 RoE: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 118 RoE: Insulin Market Size, by Type, 2015-2022 (USD Million)
Table 119 RoE: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 120 APAC: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
Table 121 APAC: Diabetes Care Devices Market Size, by Country, 2015-2022 (USD Million)
Table 122 APAC: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
Table 123 APAC: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
Table 124 APAC: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
Table 125 APAC: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 126 APAC: Insulin Market Size, by Type, 2015-2022 (USD Million)
Table 127 APAC: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 128 Japan: Diabetes Indicators, 2016
Table 129 Japan: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
Table 130 Japan: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
Table 131 Japan: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
Table 132 Japan: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
Table 133 Japan: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 134 Japan: Insulin Market Size, by Type, 2015-2022 (USD Million)
Table 135 Japan: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 136 China: Diabetes Indicators, 2016
Table 137 China: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
Table 138 China: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
Table 139 China: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
Table 140 China: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
Table 141 China: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 142 China: Insulin Market Size, by Type, 2015-2022 (USD Million)
Table 143 China: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 144 India: Diabetes Indicators, 2016
Table 145 India: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
Table 146 India: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
Table 147 India: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
Table 148 India: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
Table 149 India: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 150 India: Insulin Market Size, by Type, 2015-2022 (USD Million)
Table 151 India: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 152 RoAPAC: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
Table 153 RoAPAC: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
Table 154 RoAPAC: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
Table 155 RoAPAC: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
Table 156 RoAPAC: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 157 RoAPAC: Insulin Market Size, by Type, 2015-2022 (USD Million)
Table 158 RoAPAC: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 159 RoW: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
Table 160 RoW: Diabetes Care Devices Market Size, by Country, 2015-2022 (USD Million)
Table 161 RoW: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
Table 162 RoW: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
Table 163 RoW: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
Table 164 RoW: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 165 RoW: Insulin Market Size, by Type, 2015-2022 (USD Million)
Table 166 RoW: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 167 Latin America: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
Table 168 Latin America: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
Table 169 Latin America: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
Table 170 Latin America: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
Table 171 Latin America: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 172 Latin America: Insulin Market Size, by Type, 2015-2022 (USD Million)
Table 173 Latin America: Oral Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 174 Middle East & Africa: Diabetes Care Devices & Drugs Market, by Type, 2015-2022 (USD Million)
Table 175 Middle East & Africa: Diabetes Care Devices Market Size, by Type, 2015-2022 (USD Million)
Table 176 Middle East & Africa: Diabetes Monitoring Devices Market Size, by Type, 2015-2022 (USD Million)
Table 177 Middle East & Africa: Insulin Delivery Devices Market Size, by Type, 2015-2022 (USD Million)
Table 178 Middle East & Africa: Diabetes Care Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 179 Middle East & Africa: Insulin Market Size, by Type, 2015-2022 (USD Million)
Table 180 Middle East & Africa: Oral-Hypoglycaemic Drugs Market Size, by Type, 2015-2022 (USD Million)
Table 181 Number of Developments by the Key Companies, 2015-2017

List of Figures

Figure 1 Research Process
Figure 2 Key Executives Interviewed
Figure 3 Primary Research Techniques
Figure 4 Key Opportunities
Figure 5 Global Diabetes Care Devices & Drugs Market Size, by Type, 2015-2022 (USD Million)
Figure 6 Diabetes Monitoring Devices Dominates Diabetes Care Devices Market
Figure 7 Diabetes Care Devices & Drugs Market Overview- 2017-2022
Figure 8 Key Growth Strategies Adopted by the Leading Players -2015-2017
Figure 9 Market Dynamics
Figure 10 Rising Overweight (Including Obesity) Rates in Adults Aged 15-74 Years
Figure 11 Market Share Analysis: Diabetes Care Devices Market, 2016
Figure 12 Market Share Analysis: Diabetes Care Drugs Market, 2016
Figure 13 Global Diabetes Care Devices Market Size, by Type, 2015-2022
Figure 14 Global Diabetes Care Drugs Market Size, by Type, 2015-2022
Figure 15 Global Diabetes Care Devices & Drugs Market Size, by Country/ Region, 2015-2022 (USD Million)
Figure 16 Mortality Due to Diabetes in North America, By Age Group, 2015
Figure 17 A Snapshot of Diabetes in The U.S., 2017
Figure 18 Cost of Diabetes in Canada, 2000-2020
Figure 19 Comparative Prevalence of Diabetes in Adults in EU Countries, 2016
Figure 20 Percentage of Total Death, 2016
Figure 21 Number of Patients with Type-2 Diabetes in Germany, 2006-2014
Figure 22 Distribution of Total Expenditure Per Healthcare Item, 2013
Figure 23 Projected Rate of Obesity, 2000-2030
Figure 24 Facts & Figures of Diabetes in Italy, 2016
Figure 25 Diabetes Prevalence in EU Member Countries, 2017
Figure 26 Prevalence of Diabetes in Japan, 2000-2030
Figure 27 Healthcare Costs for Diabetes by Latin American Countries, 2010-2025 (USD Million)
Figure 28 Key Growth Strategies Adopted by Key Players -2015-2017
Figure 29 Partnerships, Agreements & Collaborations by Profiled Companies, 2015-2017
Figure 30 Approvals Received by Profiled Companies, 2015-2017
Figure 31 New Product Launches by Profiled Companies, 2015-2017
Figure 32 Expansions by Profiled Companies, 2015-2017
Figure 33 Novo Nordisk A/S: Financial Overview- 2014-2016
Figure 34 Ypsomed Ag: Financial Overview- 2015-2017
Figure 35 Abbott Labratories: Financial Overview- 2014-2016
Figure 36 Panasonic Corporation (A Parent Company of Ascensia Diabetes Care Holdings Ag): Financial Overview- 2015-2017
Figure 37 Eli Lilly And Company: Financial Overview- 2014-2016
Figure 38 Hoffmann-La Roche Ltd.: Financial Overview- 2014-2016
Figure 39 Johnson & Johnson: Financial Overview- 2014-2016
Figure 40 Medtronic Plc: Financial Overview- 2015-2017
Figure 41 Becton, Dickinson And Company: Financial Overview- 2014-2016
Figure 42 Terumo Corporation: Financial Overview- 2014-2016
Figure 43 Sanofi S.A.: Financial Overview- 2014-2016
Figure 44 Merck & Co., Inc.: Financial Overview- 2014-2016
Figure 45 Novartis AG: Financial Overview- 2014-2016
Figure 46 Astrazeneca: Financial Overview- 2014-2016
Figure 47 Boehringer Ingelheim GmbH: Financial Overview- 2014-2016

REPORT SUMMARY

Global Diabetes Care Devices & Drugs Market by Type of Devices (Continuous Blood Glucose Monitoring Devices, Test Strips, Lancets, Self-monitoring Devices, Haemoglobin A1c Testing Kits, Insulin Syringes, Insulin Pens, Insulin Pumps, Insulin Jet Injectors), and Drugs (Insulin, Oral Hypoglycaemic Agents, and Non-Insulin Injectable) – Global Opportunity Analysis and Industry Forecast To 2022 

Market Overview

Global diabetes care devices & drugs market is expected to reach USD 85,591.2 million by 2022, supported by a CAGR of 5.2% during the forecast period of 2017 to 2022. The global diabetes care devices & drugs market is mainly driven by the increasing incidence & prevalence of diabetes, technological advancements, rising obesity rate, and increasing sedentary lifestyle & improper diet. However, high cost associated with diagnosis and treatment, reimbursement issues, and lack of awareness is expected to hinder the growth of diabetes care devices & drugs market to some extent. Developments of new formulations and insulin delivery technologies serve as an opportunity for this market, whereas stringent regulations and registration process for the diabetes care devices & drugs poses significant challenge for the growth of diabetes care devices & drugs market.

Market Segmentation

The global diabetes care devices & drugs market is mainly segmented by type of devices and drugs. The diabetes care devices market by type is further segmented into diabetes monitoring devices and insulin delivery devices. The drugs market by type is further segmented into insulin, oral-hypoglycemic agents, and non-insulin injectable. Diabetes care drugs market dominated the overall market in 2016, and is expected to grow significantly in the next 5-10 years. The large share of this market is mainly attributed to the huge demand for insulin and oral hypoglycemic drugs for the treatment of type I & II diabetes. 

Geographic Overview

Geographically, the global diabetes care devices & drugs market is segmented into five major regions, namely North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. These regions are further analyzed at a country level with the detailed qualitative and quantitative analysis. North America accounted for the major share in the global diabetes care devices & drugs market in 2016, followed by Europe, and Asia-Pacific. The major share of the North America is mainly attributed to the large & growing base of diabetic patients, well-established healthcare infrastructure, higher adoption of technologically innovative diabetic care products, increasing research on diabetes, and presence of large number of leading players in the market. However, Asia-Pacific region is projected to grow at a fastest CAGR during the forecast period, due to increasing greying population, rising burden of diabetic population, various government initiatives to increase the awareness & prevention of diseases, and increasing sedentary lifestyles in developing countries such as India, & China.

Key players

The key players in the global diabetes care devices & drugs market are Novo Nordisk A/S, Ypsomed AG, Abbott, Ascensia Diabetes Care Holdings AG, Eli Lilly and Company, Hoffmann-La Roche Ltd., Johnson & Johnson, Medtronic PLC, Becton, Dickinson and Company, Terumo Corporation, Sanofi S.A., Merck & Co., Inc., Novartis AG, AstraZeneca PLC, and Boehringer Ingelheim GmbH.

Scope of the Report

Market by type

Diabetes care devices market by Type

  • Diabetes monitoring devices
  • Continuous Blood Glucose Monitoring Devices
  • Test Strips
  • Lancets
  • Self-Monitoring Devices
  • Haemoglobin A1c Testing Kits
  • Insulin delivery devices
  • Insulin Syringes
  • Insulin Pens
  • Insulin Pumps
  • Insulin Jet Injectors

Diabetes care drugs market by Type

  • Insulin
  • Rapid acting Insulin
  • Short acting Insulin
  • Intermediate acting Insulin
  • Long acting Insulin
  • Oral-hypoglycaemic drugs
  • Sulfonylureas
  • Biguanide
  • Meglitinide / Phenylalanine analogues
  • Thiazolidinediones
  • α-glucosidase inhibitors
  • Dipeptidyl peptidase -4 (DPP-4) inhibitor
  • Non-insulin injectable drugs

Market by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • Rest of World
    • Latin America
    • Middle East & Africa 

Key questions answered in the report-

  • Which are the high growth market segments in terms of type and regions/countries?
  • What is the historical market for diabetes care devices & drugs across the globe?
  • What are the market forecasts and estimates from the period 2015-2022?
  • What are the major drivers, challenges, opportunities, and trends in the global diabetes care devices & drugs market?
  • Who are the major players in the global diabetes care devices & drugs market and what share of the market do they hold?
  • Who are the major players in various countries and what share of the market do they hold?
  • What are the competitive landscapes and who are the market leaders by sub-region in the global diabetes care devices & drugs market?
  • What are the recent developments in the global diabetes care devices & drugs market?
  • What are the different strategies adopted by the major players in the global diabetes care devices & drugs market?
  • What are the geographical trends and high growth regions/ countries?
  • Who are the local emerging players in the global diabetes care devices & drugs market and how do they compete with the global players?

NEED CUSTOMIZATION?

Need Customization?

Not satisfied with the defined report scope. No worries, we can customize this report for you.
Please fill in the form below and our research analyst will get in touch with you immediately.

Reviews

There are no reviews yet.

Be the first to review “Diabetes Care Devices & Drugs Market- Global Opportunity Analysis and Industry Forecast (2017-2022)”

Your email address will not be published. Required fields are marked *